PEDIATRICS Vol. 70 No. 3 September 1982, pp. 348-353
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ben-Zvi, Z.
Right arrow Articles by Kattan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ben-Zvi, Z.
Right arrow Articles by Kattan, M.

An Evaluation of the Initial Treatment of Acute Asthma

Zvi Ben-Zvi MD1, Carin Lam MD1, Jane Hoffman MD1, Katherine C. Teets-Grimm MD1, and Meyer Kattan MD, CM1

1 Department of Pediatrics, Mount Sinai School of Medicine, New York

Two treatment regimens for the initial treatment of acute asthma in 50 patients between the ages of 12 and 20 years seen in the emergency room were evalvated. The treatments were randomized such that 26 patients received 2.5 mg of the beta2-agonist fenoterol by nebulizer and 24 patients received 0.3 mg of epinephrine followed by 0.75 mg of Sus-Phrine. Clinical assessment and spirometry were performed over a two-hour period. Both groups responded within ten minutes and peak improvement was reached within one hour. Peak expiratory flow and clinical score were better following fenoterol treatment in the first hour (P < .05). The one-second forced expiratory volume and the forced expiratory flow in the middle half of the vital capacity were greater at 20 minutes with fenoterol (P < .05). Those with more severe obstruction (forced expiratory volume < 30%) receiving aerosol therapy also had significantly greater improvement in the first 20 minutes compared with those who received injections. Four patients failed to respond to epinephrine whereas all patients showed improvement with fenoterol (P < .05). These results demonstrated that an inhaled beta2-agonist is effective in the initial treatment of acute asthma in children, regardless of severity, and avoids the need for injections.

Submitted on May 11, 1981
Accepted on October 2, 1981




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
S. Press and R. S. Lipkind
A Treatment Protocol of the Acute Asthma Patient in a Pediatric Emergency Department
Clinical Pediatrics, October 1, 1991; 30(10): 573 - 577.
[Abstract] [PDF]